Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine which was referred to the Minister of Health, under the provisions of section 24 (5) of the Act, and is set out in the Schedule hereto:
Schedule
Product: Botox
Active Ingredient: Botulinum A toxin 100U
Dosage Form: Powder for injection
New Zealand Sponsor: Allergan New Zealand Limited
Manufacturers: Allergan Berkeley, Berkeley, California, United States of America
Allergan Pharmaceuticals Ireland, Westport, County Mayo, Eire
Charles River Laboratories Biolabs Europe, Carrentrila, Ballina, County Mayo, Eire
Northview Pacific Labs, Berkeley, California, United States of America
Dated this 17th day of September 2004.
GRAEME GILLESPIE, Acting Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).